Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Varela, Rosario
DOB:	03-MAY-1956 (Age: 69)
Gender:	male
Address:	Ronda de Graciela Llorens 62 46001 Valencia (Spain)
ID:	8295-992682-3 (ECI)

Report
Date:	25-NOV-2018

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro Privado de Educación Especial Parálisis Cerebral Infantil Calle Alboraya 4 46010 Valencia (Spain)

Specimen
Collected:	25-NOV-2018

Chemistry

Test	25-NOV-2018	Reference Range	Unit
Glucose [Mass/volume] in Blood	73.3	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	10.4	7 - 18	mg/dL
Creatinine [Mass/volume] in Blood	3.2 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.1	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	140.3	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	3.9	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	105.6	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	28.6	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	6.1 L	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	5.4	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.0 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	1.0	0.2 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	58.5	39 - 117	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	44.6 H	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	33.3	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	150.9	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	185.1 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	82.2	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	45.6	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significantly elevated creatinine, suggesting impaired renal function. Mildly elevated ALT may indicate some hepatic involvement. Total protein and globulin are low, possibly reflecting decreased synthesis or increased loss. Triglycerides are elevated, indicating dyslipidemia. Other parameters are within normal limits. Renal function impairment should be further evaluated and correlated clinically.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows significantly elevated creatinine, suggesting impaired renal function. Mildly elevated ALT may indicate some hepatic involvement. Total protein and globulin are low, possibly reflecting decreased synthesis or increased loss. Triglycerides are elevated, indicating dyslipidemia. Other parameters are within normal limits. Renal function impairment should be further evaluated and correlated clinically.